Zacks Investment Research
15 Dec 2025, 16:01 UTC · 40w ago
Verdict
Headline takes no side. We score RCUS −1.00 — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
Which stocks this story touches
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More positive than 76% of relationship scores this week
[mutual] Arcus Biosciences and Gilead Sciences collaborated on the STAR-221 study and a joint domvanalimab development program.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+24.8%
Price is moving against the score
$26.87 vs $21.53 close before publication (Dec 12) · not market-adjusted
RCUS chart →
